WIN-Partners CoTSE:3183 +0.31%63 Pretax Margin % is 3.41% as of Mar. 2026, which is 16% below its 10-year median of 4.08. GuruFocus rates TSE:3183 with a GF Score™ of 63/100 and a GF Value™ of 円1,522.55 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 117 Medical Distribution companies, WIN-Partners Co ranks better than 61.54% on this metric.
The historical rank and industry rank for WIN-Partners Co's Pretax Margin % or its related term are showing as below:
TSE:3183'
s Pretax Margin % Range Over the Past 10 Years
Min: 3.41 Med: 4.08 Max: 6.09
Current: 3.41
TSE:3183's Pretax Margin % is ranked better than 61.54% of 117
companies
in the Medical Distribution industry
Industry Median: 2.31
vs TSE:3183: 3.41
WIN-Partners Co (TSE:3183) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
WIN-Partners Co Pretax Margin % Related Terms
WIN-Partners Co Pretax Margin % Historical Data
* Premium members only.
The historical data trend for WIN-Partners Co's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3183 vs MCK, CAH, COR: Pretax Margin % Comparison
For the Medical Distribution subindustry, WIN-Partners Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WIN-Partners Co Pretax Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, WIN-Partners Co's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where WIN-Partners Co's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WIN-Partners Co (TSE:3183) has a Pretax Margin % of 3.41% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on WIN-Partners Co and its competitors. This is 16% below median its historical median of 4.08. Over the past decade, WIN-Partners Co's Pretax Margin % has ranged from 3.41 to 6.09. According to the industry distribution chart, WIN-Partners Co ranks #45 out of 117 companies in the Medical Distribution industry, placing it in the top 38.5%.
Is WIN-Partners Co's Pretax Margin % too high?
WIN-Partners Co's current Pretax Margin % of 3.41% is 16% below median its 10-year median of 4.08. Over the past 10 years, this metric has ranged from a low of 3.41 to a high of 6.09. The Medical Distribution industry median Pretax Margin % is 2.31. WIN-Partners Co's value of 3.41% is 47.6% above this industry median. Based on the distribution chart, WIN-Partners Co ranks #45 out of 117 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, WIN-Partners Co has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does WIN-Partners Co's Pretax Margin % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, WIN-Partners Co ranks #45 out of 117 companies for Pretax Margin %. This puts WIN-Partners Co in the upper half of its industry. The industry median Pretax Margin % is 2.31. WIN-Partners Co's value of 3.41% is 47.6% above this benchmark. Historically, WIN-Partners Co's own Pretax Margin % has ranged from 3.41 to 6.09 over the past decade. While the company's 10-year median is 4.08 vs. the industry median of 2.31, WIN-Partners Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Distribution company?
The median Pretax Margin % among Medical Distribution companies is 2.31, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. WIN-Partners Co's current Pretax Margin % of 3.41% is 47.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on WIN-Partners Co and its competitors. For the Medical Distribution industry, the median Pretax Margin % is 2.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. WIN-Partners Co's current Pretax Margin % is 3.41%, which is 16% below median its own 10-year median of 4.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WIN-Partners Co stock overvalued right now?
Based on GuruFocus' analysis, WIN-Partners Co (TSE:3183) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,522.55, compared to a current price of 円1,285.00 — trading 15.6% below its estimated fair value. The current Pretax Margin % is 3.41%, which is 16% below median its 10-year median of 4.08 and 47.6% above the Medical Distribution industry median of 2.31. WIN-Partners Co's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For WIN-Partners Co (TSE:3183), the current Pretax Margin % is 3.41% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is WIN-Partners Co (TSE:3183) Overvalued in 2026?
Based on GuruFocus' analysis, WIN-Partners Co stock appears to be undervalued.
The current stock price of 円1,285.00 is trading 15.6% below its estimated GF Value™ of 円1,522.55.
GuruFocus considers WIN-Partners Co to be Modestly Undervalued.
Key valuation signals for TSE:3183:
Pretax Margin %: 3.41% (16% below median its 10-year median of 4.08)
GF Value™: 円1,522.55 vs. price of 円1,285.00 (15.6% below fair value)
Industry Position: 47.6% above the Medical Distribution median (#45 of 117)
No single metric tells the full story. See the TSE:3183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
WIN-Partners Co Ltd is engaged in the healthcare sector. The company provides medical devices to Japan's medical institutions. Its products offerings are Cardiovascular device, Insulin Pump, X-ray Angio System, Carotid Artery Stent, Stent Graft, among others. The company operates only in one segment which is the medical equipment sales business.
63GF Score
Get the complete analysis for TSE:3183
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3183 has been successfully added to your 
